See more : Repsol, S.A. (REPYF) Income Statement Analysis – Financial Results
Complete financial analysis of Optigenex Inc. (OPGX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Optigenex Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Centenial Surgical Suture Limited (CSURGSU.BO) Income Statement Analysis – Financial Results
- Shenzhen Original Advanced Compounds Co., Ltd. (603991.SS) Income Statement Analysis – Financial Results
- Public joint stock company NPO Nauka (NAUK.ME) Income Statement Analysis – Financial Results
- Outback Goldfields Corp. (OZ.V) Income Statement Analysis – Financial Results
- Avon Protection plc (AVNBF) Income Statement Analysis – Financial Results
Optigenex Inc. (OPGX)
About Optigenex Inc.
Optigenex Inc. engages in the manufacture and sale of healthy age management and beauty care products. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging. It serves manufacturers, distributors, and retailers worldwide in the dietary supplement, as well as anti-aging topical skin care, cosmetic, and cosmeceutical market categories. The company is based in Melissa, Texas.
| Metric | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|
| Revenue | 465.97K | 300.92K | 277.83K | 339.07K |
| Cost of Revenue | 568.94K | 1.52M | 510.96K | 229.68K |
| Gross Profit | -102.97K | -1.21M | -233.13K | 109.39K |
| Gross Profit Ratio | -22.10% | -403.68% | -83.91% | 32.26% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.29M | 2.75M | 4.73M | 4.50M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.29M | 3.69M | 6.00M | 4.50M |
| Cost & Expenses | 1.86M | 5.20M | 6.51M | 4.73M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 204.11K | 1.55M | 529.03K | 430.69K |
| EBITDA | -1.19M | -3.35M | -5.71M | -5.36M |
| EBITDA Ratio | -531.95% | -3,306.32% | -1,612.04% | -752.68% |
| Operating Income | 1.39M | 4.90M | 6.24M | 4.39M |
| Operating Income Ratio | 298.48% | 1,629.23% | 2,244.34% | 1,294.14% |
| Total Other Income/Expenses | -1.39M | -3.37M | -2.01M | -1.41M |
| Income Before Tax | 2.68M | 11.48M | 4.98M | 2.98M |
| Income Before Tax Ratio | 575.75% | 3,815.29% | 1,792.73% | 879.70% |
| Income Tax Expense | 1.51M | 2.44M | 733.66K | 1.41M |
| Net Income | -2.90M | -7.36M | -7.00M | -5.79M |
| Net Income Ratio | -621.88% | -2,444.96% | -2,518.13% | -1,708.57% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports